Hong Yang
State Key Laboratory Of Oncology In South China
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Serum cytokines predict response and survival in esophageal squamous cell carcinoma receiving chemoradiotherapy combined with anti-PD-1 antibody: analyses of two phase II clinical trials.
Journal: Journal for immunotherapy of cancer
Published: December 30, 2025
Correction: Impact of lymph node dissection on survival after neoadjuvant immunochemotherapy for esophageal squamous cell cancer: a double-center real-world retrospective study.
Journal: Cancer immunology, immunotherapy : CII
Published: October 29, 2025
Integrative proteomic characterization of human lung adenocarcinoma with KRAS G12 mutations reveals molecular pathogenesis.
Journal: Journal of advanced research
Published: March 18, 2025
Circulating tumor DNA as a marker of molecular residual disease in resected esophageal squamous cell carcinoma.
Journal: Molecular biomedicine
Published: December 20, 2024
Proteomics analysis and immune profiling reveal regulators of PD-L1 in oesophageal squamous cell carcinoma.
Journal: British journal of cancer
Published: November 14, 2024
Impaired TGF-β signaling via AHNAK family mutations elicits an esophageal cancer subtype with sensitivities to genotoxic therapy and immunotherapy.
Journal: Cancer immunology, immunotherapy : CII
Published: March 22, 2024
ASO Author Reflections: Treatment Strategies for Locally Advanced Borderline Resectable Esophageal Squamous Cell Carcinoma.
Journal: Annals of surgical oncology
Published: October 17, 2023
Predictive role of ctDNA in esophageal squamous cell carcinoma receiving definitive chemoradiotherapy combined with toripalimab.
Journal: Nature communications
Published: June 29, 2023
A 3-Year Survival Update from a Phase 2 Study of Paclitaxel Plus Cisplatin and 5-Fuorouracil Induction Chemotherapy for Locally Advanced Borderline-Resectable Esophageal Squamous Cell Carcinoma: The NEOCRTEC-1601 Clinical Trial.
Journal: Annals of surgical oncology
Published: May 31, 2023
ASO Author Reflections: Radiomics-Based Prediction of Individual Lymph Node Metastatic Status in Esophageal Squamous Cell Carcinoma.
Journal: Annals of surgical oncology
Published: June 20, 2022
Prediction of Individual Lymph Node Metastatic Status in Esophageal Squamous Cell Carcinoma Using Routine Computed Tomography Imaging: Comparison of Size-Based Measurements and Radiomics-Based Models.
Journal: Annals of surgical oncology
Published: May 16, 2022
Paclitaxel plus cisplatin and 5-fluorouracil induction chemotherapy for locally advanced borderline-resectable esophageal squamous cell carcinoma: a phase II clinical trial.
Journal: Esophagus : official journal of the Japan Esophageal Society
Published: January 19, 2021
Last Updated: 09/26/2026